The benefits of a Quality System Audit Program
Accelerate patient access to cell and gene therapies
Standardization in cell therapy industry is a race against time
Accellerate Summit highlights needs and challenges in standardization
The challenge of multiple audits and redundant training
A case study from UCLA Health
Developing and managing a strong collection center network
On-demand webinar available
Industry stakeholders propose unified CAR T toxicity grading scale
CIBMTR Cellular Therapy Registry recommended to meet outcomes data reporting requirements
‘There is no room for error’ in cell and gene therapy logistics
Delivering life-saving therapies on time, every time
How standardizing audits can help deliver high-quality therapies faster
Overview of the Quality System Audit Program
